<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01092377</url>
  </required_header>
  <id_info>
    <org_study_id>FeFA study 2010</org_study_id>
    <nct_id>NCT01092377</nct_id>
  </id_info>
  <brief_title>The Effects of Iron and Omega-3 Fatty Acid Supplementation on Cognition and Immune Function in Iron Deficient Children</brief_title>
  <acronym>FeFA</acronym>
  <official_title>The Effects of Iron and Omega-3 Fatty Acid Supplementation, Alone and in Combination, on Cognition, Immune System and Gut Microbiota: a Randomized, Double-blind, 2x2 Intervention Trial in Iron Deficient South African Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North-West University, South Africa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Research Council, South Africa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>North-West University, South Africa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine if providing iron and a mixture of DHA and EPA, alone
      and in combination, to children with iron deficiency and poor n-3 fatty acid intake will
      improve their cognitive performance, activity levels and immune system.

      Additionally, the effects on iron and fatty acid status, and gut microbiota, will be
      assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In populations of low socio economic status, such as found in South Africa, iron deficiency
      coexisting with a low intake of n-3 fatty acids could synergistically compromise both the
      intellectual performance and immune system of children.

      Therefore, specific cognitive processes (domains) and specific immunization status markers
      and immune function modulators, that have been found to be affected by iron and n-3 fatty
      acid deficiency in children in previous studies will be assessed.

      This will be the first human study that assesses the interactions of iron and n-3 fatty acid
      supplementation to iron deficient children in a two-by-two factorial, randomized,
      double-blind, placebo-controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cognitive and behavioral performance and immune function</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in activity levels, gut microbiota, iron status, fatty acid status and gene expression</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">320</enrollment>
  <condition>Iron Deficiency</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>DHA/EPA capsules and iron tablet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA/EPA and placebo tablet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo capsules &amp; placebo tablet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>iron tablet and placebo capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA and EPA Fish Oil capsule</intervention_name>
    <description>2 DHA/EPA capsules on 4 days per week containing totally 420 mg DHA and 80 mg EPA, providing an average dose of 285.7 mg n-3 fatty acids per day</description>
    <arm_group_label>DHA/EPA capsules and iron tablet</arm_group_label>
    <arm_group_label>DHA/EPA and placebo tablet</arm_group_label>
    <other_name>Provided by Burgerstein AG (Rapperswil, Switzerland)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron tablet</intervention_name>
    <description>1 iron tablet containing 50 mg of iron as ferrous sulfate will be administered on 4 days per week, providing an average iron dose of 28.6 mg iron per day.</description>
    <arm_group_label>DHA/EPA capsules and iron tablet</arm_group_label>
    <arm_group_label>placebo capsules &amp; placebo tablet</arm_group_label>
    <other_name>Provided by Lomapharm (Paul Lohmann GmbH, Emmertal, Germany)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo tablet</intervention_name>
    <description>Placebo tablet will be administered on 4 days per week and will be identical in appearance to the iron tablet.</description>
    <arm_group_label>DHA/EPA and placebo tablet</arm_group_label>
    <arm_group_label>placebo capsules &amp; placebo tablet</arm_group_label>
    <other_name>Provided by Lomapharm (Paul Lohmann GmbH, Emmertal, Germany)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo capsule</intervention_name>
    <description>Placebo capsules contain medium chain triglycerides and will be identical in appearance and total fat content to the DHA/EPA capsules.</description>
    <arm_group_label>placebo capsules &amp; placebo tablet</arm_group_label>
    <arm_group_label>iron tablet and placebo capsules</arm_group_label>
    <other_name>Will be provided by R.P. Scherer GmbH (Eberbach, Germany)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 6-10 years

          -  Iron deficiency (Serum ferritin &lt; 20 µg/L or zinc protoporphyrin &gt; 70 µmol/mol heme in
             washed erythrocytes or TfR &gt; 8.3 mg/L) with no or mild anaemia

        Exclusion Criteria:

          -  Chronic illness

          -  Severe anemia (Hb &lt; 80 g/L)

          -  Use of iron or n-3 fatty acid containing supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marius Smuts, PhD</last_name>
    <role>Study Director</role>
    <affiliation>North-West University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael B Zimmermann, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Linda Malan, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>North-West University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeannine Baumgartner, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valley of a Thousand Hills</name>
      <address>
        <city>Botha's Hill</city>
        <state>KwaZulu-Natal</state>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>January 13, 2011</last_update_submitted>
  <last_update_submitted_qc>January 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Marius Smuts</name_title>
    <organization>North-West University, South Africa</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

